.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Medtronic
Chinese Patent Office
Federal Trade Commission
Fuji
Julphar
Chubb
Baxter
Novartis
US Department of Justice

Generated: December 13, 2017

DrugPatentWatch Database Preview

NPH ILETIN II Drug Profile

« Back to Dashboard

When do Nph Iletin Ii patents expire, and when can generic versions of Nph Iletin Ii launch?

Nph Iletin Ii is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in NPH ILETIN II is insulin susp isophane purified pork. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin susp isophane purified pork profile page.

Summary for NPH ILETIN II

US Patents:0
Applicants:1
NDAs:2
Clinical Trials: 1
Drug Prices:see details
DailyMed Link:NPH ILETIN II at DailyMed
Drug patent expirations by year for NPH ILETIN II

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LillyNPH ILETIN IIinsulin susp isophane purified beefINJECTABLE;INJECTION018479-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LillyNPH ILETIN II (PORK)insulin susp isophane purified porkINJECTABLE;INJECTION018345-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
UBS
Medtronic
Accenture
Baxter
Express Scripts
Queensland Health
McKinsey
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot